(Q38291224)

1 September 2017

AH6809 antagonizes non-small cell lung cancer prostaglandin receptors (English)

1 reference

1 September 2017

Marchessini Casibang

1

1 reference

PubMed ID

11891031

1 September 2017

Terry W Moody

series ordinal

2

1 reference

1 September 2017

1 April 2002

1 reference

1 September 2017

1 reference

1 September 2017

36

1 reference

1 September 2017

1

1 reference

1 September 2017

33-42

1 reference

Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer

1 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900476-7

7 January 2021

Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900476-7

7 January 2021

A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900476-7

7 January 2021

Peptides and growth factors in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900476-7

7 January 2021

Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900476-7

7 January 2021

Lipoxygenase inhibitors prevent lung carcinogenesis and inhibit non-small cell lung cancer growth

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900476-7

7 January 2021

Prostaglandin E2 and vasoactive intestinal peptide increase vascular endothelial cell growth factor mRNAs in lung cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900476-7

7 January 2021

Molecular cloning and expression of human EP3 receptors: evidence of three variants with differing carboxyl termini

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900476-7

7 January 2021

Cloning and expression of three isoforms of the human EP3 prostanoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900476-7

7 January 2021

Bombesin-like peptides elevate cytosolic calcium in small cell lung cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900476-7

7 January 2021

Bombesin stimulates c-fos and c-jun mRNAs in small cell lung cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900476-7

7 January 2021

Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900476-7

7 January 2021

Characterization of prostanoid relaxant/inhibitory receptors (psi) using a highly selective agonist, TR4979.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900476-7

7 January 2021

In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900476-7

7 January 2021

Molecular cloning and expression of a rat prostaglandin E2 receptor of the EP2 subtype

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900476-7

7 January 2021

Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900476-7

7 January 2021

Roles of prostanoids revealed from studies using mice lacking specific prostanoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900476-7

7 January 2021

Aspirin use and reduced risk of fatal colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900476-7

7 January 2021

Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900476-7

7 January 2021

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900476-7

7 January 2021

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900476-7

7 January 2021

Inhibition of lung tumourigenesis by sulindac: comparison of two experimental protocols.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900476-7

7 January 2021

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900476-7

7 January 2021

Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900476-7

7 January 2021

Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900476-7

7 January 2021

10.1016/S0169-5002(01)00476-7

Identifiers

DOI

1 reference

1 September 2017

1 reference

PubMed ID

11891031